Study on the Application of Doxorubicin-Loaded Magnetic Nanodrugs in Targeted Therapy of Liver Cancer

Author:

Wang Lei1,Liang Liping1,Shi Shuzhen1,Wang Chao2ORCID

Affiliation:

1. Department of Pharmacy, Qingdao Jiaozhou Central Hospital, Qingdao, 266300 Shandong, China

2. Pharmacy Department of Qingdao Chest Hospital, Qingdao, 266043 Shandong, China

Abstract

Doxorubicin (DOX) has been widely recognized as effective in anticancer therapy; however, the additional organ toxicity and low targeting of DOX in antitumor activity remains unaddressed. The aim of this study was to use the drug carrier dextran/polylactic acid (DEX/PLA) and paramagnetic Fe3O4 to improve the targeting of DOX in liver cancer treatment while reducing its potential organ toxicity. Our experimental results show that the combination drug (Fe3O4@DEX/PLA-DOX) exhibits strong hepatocarcinogenic inhibition and low cytotoxicity and that this modified drug provides a better option for clinical liver cancer treatment.

Publisher

Hindawi Limited

Subject

Biomedical Engineering,Bioengineering,Medicine (miscellaneous),Biotechnology

Reference30 articles.

1. Integrative bioinformatics analysis of KPNA2 in six major human cancers;C. B. Xu;Open Medicine,2021

2. Liver transplantation for secondary liver tumours: the difficult balance between survival and recurrence;P. D. Line;Journal of Hepatology,2020

3. Progress and prospects of biomarkers in primary liver cancer;Y. X. Gao;International Journal of Oncology,2020

4. Primary liver cancers: intrahepatic cholangiocarcinoma and hepatocellular carcinoma;J. C. Mejia;Surgical Clinics of North America,2020

5. International trends in liver cancer incidence, overall and by histologic subtype, 1978-2007;J. L. Petrick;International Journal of Cancer,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3